What is Sihuan Pharmaceutical Holdings Group Days Inventory?
Sihuan Pharmaceutical Holdings GroupSHPHF 51 Days Inventory is 230.89 as of Dec. 2025, which is 8% below its 10-year median of 250.84. GuruFocus rates SHPHF with a GF Score™ of 51/100 and a GF Value™ of $0.18 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 916 Drug Manufacturers companies, Sihuan Pharmaceutical Holdings Group ranks worse than 69.98% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sihuan Pharmaceutical Holdings Group's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.79.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sihuan Pharmaceutical Holdings Group's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.37.
Sihuan Pharmaceutical Holdings Group (OTCPK:SHPHF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sihuan Pharmaceutical Holdings Group's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sihuan Pharmaceutical Holdings Group's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sihuan Pharmaceutical Holdings Group Days Inventory Related Terms
Sihuan Pharmaceutical Holdings Group Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group Days Inventory Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sihuan Pharmaceutical Holdings Group Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group (SHPHF) has a Days Inventory of 230.89 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. This is near median its historical median of 250.84. Over the past decade, Sihuan Pharmaceutical Holdings Group's Days Inventory has ranged from 82.48 to 380.17. According to the industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #641 out of 916 companies in the Drug Manufacturers industry, placing it in the top 70%.
Is Sihuan Pharmaceutical Holdings Group's Days Inventory too high?
Sihuan Pharmaceutical Holdings Group's current Days Inventory of 230.89 is near median its 10-year median of 250.84. Over the past 10 years, this metric has ranged from a low of 82.48 to a high of 380.17. The Drug Manufacturers industry median Days Inventory is 164.43. Sihuan Pharmaceutical Holdings Group's value of 230.89 is 40.4% above this industry median. Based on the distribution chart, Sihuan Pharmaceutical Holdings Group ranks #641 out of 916 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sihuan Pharmaceutical Holdings Group has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sihuan Pharmaceutical Holdings Group's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #641 out of 916 companies for Days Inventory. This places Sihuan Pharmaceutical Holdings Group in the lower half of its industry. The industry median Days Inventory is 164.43. Sihuan Pharmaceutical Holdings Group's value of 230.89 is 40.4% above this benchmark. Historically, Sihuan Pharmaceutical Holdings Group's own Days Inventory has ranged from 82.48 to 380.17 over the past decade. While the company's 10-year median is 250.84 vs. the industry median of 164.43, Sihuan Pharmaceutical Holdings Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 916 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sihuan Pharmaceutical Holdings Group's current Days Inventory of 230.89 is 40.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sihuan Pharmaceutical Holdings Group's current Days Inventory is 230.89, which is near median its own 10-year median of 250.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sihuan Pharmaceutical Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group (SHPHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.18, compared to a current price of $0.13 — trading 27.9% below its estimated fair value. The current Days Inventory is 230.89, which is near median its 10-year median of 250.84 and 40.4% above the Drug Manufacturers industry median of 164.43. Sihuan Pharmaceutical Holdings Group's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sihuan Pharmaceutical Holdings Group (SHPHF), the current Days Inventory is 230.89 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sihuan Pharmaceutical Holdings Group (SHPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group stock appears to be undervalued.
The current stock price of $0.13 is trading 27.9% below its estimated GF Value™ of $0.18.
GuruFocus considers Sihuan Pharmaceutical Holdings Group to be Modestly Undervalued.
Key valuation signals for SHPHF:
Days Inventory: 230.89 (near median its 10-year median of 250.84)
GF Value™: $0.18 vs. price of $0.13 (27.9% below fair value)
Industry Position: 40.4% above the Drug Manufacturers median (#641 of 916)
No single metric tells the full story. See the SHPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sihuan Pharmaceutical Holdings Group Business Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
51GF Score
Get the complete analysis for SHPHF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPHF has been successfully added to your 
